Pregled bibliografske jedinice broj: 781952
Antithrombotics in heart failure
Antithrombotics in heart failure // Croatian medical journal, 55 (2014), 6; 621-627 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 781952 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antithrombotics in heart failure
Autori
Miličić, Davor ; Samardžić, Jure ; Petričević, Mate
Izvornik
Croatian medical journal (0353-9504) 55
(2014), 6;
621-627
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
antithrombotic agents; antiplatelet agents; anticoagulant agents; heart failure; review
Sažetak
Heart failure (HF) is a common clinical condition associated with high morbidity and mortality rate despite the significant improvements in pharmacotherapy and implementation of medical procedures which have increased survival of these patients. It is known that patients with HF are at an increased risk of developing arterial and venous thrombosis which compound the high rate of adverse events and fatal outcomes. Many HF patients receive antithrombotic therapy routinely due to presence of a specific indication for their use like ischemic heart disease or atrial fibrillation. However, to date, there is no solid evidence to support the routine use of antithrombotic agents in all HF patients. In this paper, we review
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081875-1993 - Otpornost na antitrombocitne lijekove u ishemijskoj bolesti srca i mozga (Miličić, Davor, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE